Webinar: How to maximise value & avoid failure during life sciences dealmaking

Pills spilling out of a bottle

Life sciences webinar invitation

During this webinar, a fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions.

Please complete the form at the bottom of the page to access the on-demand recording.

Topics discussed include:

  • The importance of collaboration as a driver of innovation
  • The current policy landscape and its impact on R&D and investment
  • The dos and don'ts for creating successful transaction agreements
  • Real-world takeaways on dealmaking and integration best practices

11-Apr-2023 23:40:47
Related Articles
Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions
by Philip Whitchelo

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture

Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture
by Philip Whitchelo

Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 2 | Information Governance

Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 2 | Information Governance
by Philip Whitchelo

Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->